Christopher Doyle, Ph.D.

Christopher Doyle, Ph.D., senior director of IBC Services at WCG, works with research sites, sponsors, and CROs to ensure human gene transfer clinical trials are conducted safely and efficiently. Prior to joining WCG in early 2018, Chris was a research fellow at the Albert Einstein College of Medicine, where he explored mechanisms of antibody activity against Streptococcus pneumoniae.

Chris received his BA in Biology from Assumption College in 2008 and his Ph.D. in Molecular Genetics and Microbiology from Stony Brook University in 2014, where he studied the pathogenesis of Francisella tularensis in a high containment Biosafety Level 3 laboratory. Chris sits on the board of directors for the Northwest Association for Biomedical Research (NWABR), serves as an ad-hoc peer reviewer for Infection and Immunity, mBio, and Microbiology Spectrum, and is a member of the American Society for Microbiology (ASM) and the American Biological Safety Association (ABSA).